Spruce Biosciences (NASDAQ:SPRB – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.06, Zacks reports. Spruce Biosciences had a negative return on equity of 59.94% and a negative net margin of 450.38%. The company had revenue of $0.60 […]